Context Therapeutics Inc (CNTX)
1.86
+0.01
(+0.54%)
USD |
NASDAQ |
Sep 27, 16:00
1.85
-0.01
(-0.54%)
After-Hours: 20:00
Context Therapeutics Cash from Operations (Quarterly): -3.356M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.356M |
| March 31, 2024 | -4.361M |
| December 31, 2023 | -7.227M |
| September 30, 2023 | -3.461M |
| June 30, 2023 | -4.631M |
| March 31, 2023 | -5.728M |
| December 31, 2022 | -3.930M |
| September 30, 2022 | -2.994M |
| June 30, 2022 | -2.805M |
| Date | Value |
|---|---|
| March 31, 2022 | -3.820M |
| December 31, 2021 | -4.962M |
| September 30, 2021 | -0.0436M |
| June 30, 2021 | -2.079M |
| March 31, 2021 | -1.715M |
| December 31, 2020 | -0.176M |
| September 30, 2020 | -0.3502M |
| June 30, 2020 | -0.321M |
| March 31, 2020 | -0.1874M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-7.227M
Minimum
Dec 2023
-0.0436M
Maximum
Sep 2021
-2.897M
Average
-3.175M
Median
Cash from Operations (Quarterly) Benchmarks
| Collegium Pharmaceutical Inc | 67.40M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.854M |
| Theriva Biologics Inc | -3.452M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 94.80M |
| Free Cash Flow | -18.40M |
| Free Cash Flow Per Share (Quarterly) | -0.0611 |
| Free Cash Flow Yield | -38.48% |